$MRVL

Marvell Stock: The AI Growth Story Is Getting Bigger, But the Google Deal Is Still a Problem

Marvell (MRVL) expects a Google deal to generate up to $120B in revenue by 2033, with significant impact post-2028. Despite raising revenue guidance, shares fell 10% due to slower-than-expected deal benefits. MRVL trades at 51x forward earnings, with analysts forecasting 47.8% EPS growth in 2027 and 58.9% in 2028. Analysts remain bullish, with an average price target of $290.94, implying 43% upside.

Original reporting
Published Sep 2, 2026, 10:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 2, 2026, 11:34 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Marvell Stock: The AI Growth Story Is Getting Bigger, But the Google Deal Is Still a Problem — source image
Decision brief

The 30-second read

$MRVLNeutralLow
01

Why it matters

The article reiterates existing guidance without new data, offering limited actionable insight.

02

Market read

Primarily relevant to traders focused on semiconductor stocks and AI chip demand; limited broader market impact.

03

What to watch

Potential upside from other undisclosed Google collaborations and long-term AI chip demand.

Relevance 4/10Novelty 2/10Timing: none

Background

Marvell (MRVL) is a semiconductor company partnering with Google on custom AI chips; recent guidance raised but stock fell 10% on perceived timing lag.

Company-level read

Ticker impact

$MRVLNeutralMedium confidence
Context

Marvell raised FY2027-28 revenue guidance and discussed the timing of its Google custom-chip deal, causing a 10% stock decline.

Expected impact

Potential modest upside if guidance holds, but downside risk if revenue realization stalls.

Evidence & confidence

Guidance numbers are already public; the article adds no new data, only commentary on timing.

Market effects

Highlights broader AI/custom-chip demand and the risk of delayed monetization for similar fabless firms.

Limited to US semiconductor sector; no broader regional effect.

Minimal, as the story centers on a single company's deal with Google.

Counterpoint

Investors could view the price dip as a buying opportunity if they believe the Google deal will accelerate.

Key entities

  • Marvell Technology

    US-listed semiconductor firm (ticker MRVL).

  • Google

    Potential large investor in Marvell's custom-chip business.

Related articles

$TSMMedAI 8/10

Marvell Technology and Taiwan Semiconductor are No-Brainer Picks: They Have What Wins in a Gold Rush

Taiwan Semiconductor (TSM) and Marvell (MRVL) reported strong earnings, positioning them as key players in AI infrastructure. TSM's Q2 2026 revenue rose 36% YoY to $40.2B, with advanced nodes driving 77% of wafer revenue. MRVL's Q2 2027 revenue increased 36.5% YoY to $2.74B, with data center revenue up 46% YoY. Both companies are seen as essential for AI development, with TSM benefiting from broad industry demand and MRVL tied to hyperscaler custom silicon cycles.

$TSMHighAI 8/10

Marvell Technology and Taiwan Semiconductor are No

Taiwan Semiconductor (TSM) and Marvell (MRVL) reported strong earnings, with TSM posting $40.20B revenue and $4.31 EPS, while MRVL saw 36.5% revenue growth and 46% data center revenue increase. TSM's advanced nodes drove 77% of wafer revenue, and MRVL's custom silicon business is expected to double by fiscal 2028. Both companies are key players in AI infrastructure.

$MRVLMedAI 8/10

Marvell stock is down 36% from recent all-time highs; can it get its mojo back?

Marvell Technology (MRVL) shares have fallen 36% from their all-time high, trading at $213.33 in pre-market. Despite a 226% gain over the past year, the stock dropped 7.9% post-earnings due to margin compression concerns and deferred long-term guidance. The company reported Q2 revenue of $2.74B (+37% YoY) and raised FY2027 guidance to ~$12B. Analysts remain bullish, with targets up to $400, but bears cite margin pressures and potential AI capex slowdowns. Investor Day in October is a key catalys

$MRVLHighAI 8/10

MRVL Stock Heads For Worst Day In A Month After Q2: Analyst Sees Blue-Chip Customers, Broad Portfolio As Healthy Growth Signals

Marvell Technology (MRVL) shares fell 8.2% premarket after Q2 results, despite a new AI chip deal with Google. Analysts highlighted its blue-chip customers and diversified portfolio as growth drivers. Morningstar raised its price target to $300, while Goldman Sachs maintained a 'Neutral' rating with a $195 target. MRVL reported $2.74B in sales, up 37%, and raised fiscal 2028 sales guidance to $18B.